Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Buy
61
CILJF Quote, Financials, Valuation and Earnings
Last price:
$1.81
Seasonality move
:
0.68%
Day range:
$1.81 - $1.85
52-week range:
$1.27 - $2.64
Dividend yield:
4.88%
P/E ratio:
3.43x
P/S ratio:
1.21x
P/B ratio:
0.73x
Volume:
4.7K
Avg. volume:
7.7K
1-year change:
35.58%
Market cap:
$51.2B
Revenue:
$42.2B
EPS (TTM):
$0.53
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, China Life Insurance has -- downside to fair value with a price target of -- per share.
CILJF vs. S&P 500
-
Over the past 5 trading days, China Life Insurance has overperformed the S&P 500 by 0.01% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
China Life Insurance does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
China Life Insurance revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter China Life Insurance reported revenues of $7.6B.
Earnings Growth
-
China Life Insurance earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter China Life Insurance reported earnings per share of $0.01.
Enterprise value:
47.5B
EV / Invested capital:
--
Price / LTM sales:
1.21x
EV / EBIT:
2.95x
EV / Revenue:
1.12x
PEG ratio (5yr expected):
0.03x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
1.71%
Net Income Margin (TTM):
35.34%
Return On Equity:
21.96%
Return On Invested Capital:
20.54%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $124.2B | $38.1B | $42.2B | $13.2B | $7.6B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $0.17 | $0.26 | $0.53 | $0.06 | $0.01 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $208.2B | $250B | $284.1B | $347.3B | $11.9B | |
| Total Assets | $650.9B | $767.6B | $761.2B | $797.6B | $927.3B | |
| Current Liabilities | $33.1B | $34.9B | $28.3B | $1.4B | $1.7B | |
| Total Liabilities | $581B | $691.1B | $696.7B | $749.9B | $855.9B | |
| Total Equity | $69.9B | $76.4B | $64.5B | $47.6B | $71.4B | |
| Total Debt | $8.3B | $8.5B | $6.9B | $6.7B | $6.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -$24.6B | -$60B | -$49.4B | -$18.8B | -$5.4B | |
| Cash From Financing | -$17.9B | $8.5B | -$12.1B | $8.2B | $2.5B | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
CILJF
Sector
Market Cap
$51.2B
$601.7M
Price % of 52-Week High
68.56%
83.79%
Dividend Yield
4.88%
2.08%
Shareholder Yield
--
3.96%
1-Year Price Total Return
35.58%
7.93%
Beta (5-Year)
0.201
0.555
Dividend yield:
4.88%
Annualized payout:
$0.09
Payout ratio:
25.13%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$1.79
200-day SMA
Buy
Level
$1.79
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$1.79
Relative Strength Index (RSI14)
Sell
Level
47.43
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
-14.8148
50-day SMA
Sell
Level
$1.92
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.2282)
Sell
CA Score
(Annual)
Level (-2.3495)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (0.0834)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
With headquarters in Beijing and having around 20% share, China Life Insurance is the largest life insurance company in China. The firm offers group and individual life insurance through exclusive agents, bancassurance, and other marketing platforms. While the bulk of profits stem from life insurance policies, additional operations include short-term policies such as accident and health insurance. The company is currently undergoing a business transformation toward the sale of long-term protection products and away from short-term and single-premium products.
Stock Forecast FAQ
In the current month, CILJF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CILJF average analyst price target in the past 3 months is --.
-
Where Will China Life Insurance Stock Be In 1 Year?
According to analysts, the consensus estimate is that China Life Insurance share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About China Life Insurance?
Analysts are divided on their view about China Life Insurance share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that China Life Insurance is a Sell and believe this share price will rise from its current level to --.
-
What Is China Life Insurance's Price Target?
The price target for China Life Insurance over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CILJF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for China Life Insurance is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CILJF?
You can purchase shares of China Life Insurance via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase China Life Insurance shares.
-
What Is The China Life Insurance Share Price Today?
China Life Insurance was last trading at $1.81 per share. This represents the most recent stock quote for China Life Insurance. Yesterday, China Life Insurance closed at $1.81 per share.
-
How To Buy China Life Insurance Stock Online?
In order to purchase China Life Insurance stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Is it Too Late to Buy Gold?
Amid deep uncertainties about the future of the US economy,…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is up 23.1% over the past day.
Sell
35
RGC alert for Apr 30
Regencell Bioscience Holdings [RGC] is down 11.18% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 14.88% over the past day.
